EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma

Tao Wang iD, Yu Zhou, Hui Bao, Bo Liu, Min Wang, Lei Wang, Tiejun Pan

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Tao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, General Hospital of the Central Theater Command, Wuhan, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The general Hospital of the Centrol Theater Command.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma (RCC) is the most aggressive subtype of kidney tumour with a poor prognosis and an increasing incidence rate worldwide. Brusatol, an essential active ingredient derived from Brucea javanica, exhibits potent antitumour properties. Our study aims to explore a novel treatment strategy for RCC patients. We predicted 37 molecular targets of brusatol based on the structure of brusatol, and MEF2A (Myocyte Enhancer Factor 2A) was selected as our object through bioinformatic analyses. We employed various experimental techniques, including RT‐PCR, western blot, CCK8, colony formation, immunofluorescence, wound healing, flow cytometry, Transwell assays and xenograft mouse models, to investigate the impact of MEF2A on RCC. MEF2A expression was found to be reduced in patients with RCC, indicating a close correlation with MEF2A deubiquitylation. Additionally, the protective effects of brusatol on MEF2A were observed. The overexpression of MEF2A inhibits RCC cell proliferation, invasion and migration. In xenograft mice, MEF2A overexpression in RCC cells led to reduced tumour size compared to the control group. The underlying mechanism involves the inhibition of RCC cell proliferation, invasion, migration and epithelial‐mesenchymal transition (EMT) through the modulation of Wnt/β‐catenin signalling. Altogether, we found that MEF2A overexpression inhibits RCC progression by Wnt/β‐catenin signalling, providing novel insight into diagnosis, treatment and prognosis for RCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsAnimalsHumansMicebeta CateninCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticMEF2 Transcription FactorsWnt Signaling PathwayQuassins

Stichwörter der Autor:innen

BrusatolMEF2AWnt/beta-cateninrenal cell carcinomaubiquitylation

Substanzen

beta CateninMEF2 Transcription FactorsbrusatolQuassinsMEF2A protein, human

Autor:innen und Institutionen

  • Department of Urology, General Hospital of the Central Theater Command, Wuhan, China.
  • Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China.

ORCID-Profile: Tao Wang

Förderung

  • The general Hospital of the Centrol Theater Command

Zitieren

APA

Wang, T., Zhou, Y., Bao, H., Liu, B., Wang, M., Wang, L., & Pan, T. (2023). Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17972

Vancouver

Wang T, Zhou Y, Bao H, Liu B, Wang M, Wang L, et al. Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17972

BibTeX
@article{Wang2023,
  author = {Wang, Tao and Zhou, Yu and Bao, Hui and Liu, Bo and Wang, Min and Wang, Lei and Pan, Tiejun},
  title = {Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17972}
}
Kostenlos starten →